Alzheimer’s disease is a neurodegenerative disease characterized by cognitive alterations, cerebral atrophy [1] and neuropathological lesions including neuronal loss [2], accumulation of misfolded and aggregated β-amyloid peptide and tau proteins [3]. This evidence concerns the gene MAPT and early-onset autosomal dominant Alzheimer disease.